Chlortetracycline, a Novel Arf Inhibitor That Decreases the Arf6-Dependent Invasive Properties of Breast Cancer Cells

Chlortetracycline, a Novel Arf Inhibitor That Decreases the Arf6-Dependent Invasive Properties of Breast Cancer Cells

Breast cancer is a major disease for women worldwide, where mortality is associated with tumour cell dissemination to distant organs. While the number of efficient anticancer therapies increased in the past 20 years, treatments targeting the invasive properties of metastatic tumour cells are still a...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Eric Macia, Monserrat Vazquez-Rojas, Alessia Robiolo, Racha Fayad, Sophie Abélanet, Isabelle Mus-Veteau, Fabien Fontaine-Vive, Mohamed Mehiri, Frédéric Luton, Michel Franco
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: MDPI AG 2021-02-01
Sarja:Molecules
Aiheet:
small G protein
inhibitor
cell invasion
Arf6
breast cancer
chlortetracycline
Linkit:https://www.mdpi.com/1420-3049/26/4/969

Internet

https://www.mdpi.com/1420-3049/26/4/969

Samankaltaisia teoksia